Stay updated on AVB-S6-500 Safety/Efficacy in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the AVB-S6-500 Safety/Efficacy in IgA Nephropathy Clinical Trial page.

Latest updates to the AVB-S6-500 Safety/Efficacy in IgA Nephropathy Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed from the version history.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision history updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.2%

- Check39 days agoChange DetectedRecord History shows multiple version updates to the study record, including changes to Recruitment Status, Study Design, Outcome Measures, and Contacts/Locations, with a 'Quality Control Review Has Not Concluded' notice.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision v3.4.3 was added and v3.4.2 removed from the history, indicating a minor update to the page's version history.SummaryDifference0.1%

- Check75 days agoChange DetectedThe history shows a new revision entry (v3.4.2) was added, and an older revision (v3.4.1) along with a government funding notice were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check82 days agoChange DetectedThe history page now includes a government funding lapse notice and updates the site version to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

Stay in the know with updates to AVB-S6-500 Safety/Efficacy in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AVB-S6-500 Safety/Efficacy in IgA Nephropathy Clinical Trial page.